Nutrafol Hair Serum Review: The Exosome Claim, the Data, the Price
A $49 drug-free scalp serum built around "ashwagandha exosomes". What that word means here, what evidence we could find, and what it costs.
Nutrafol Hair Serum is a drug-free cosmetic for the scalp, sold at $49 a bottle, whose headline ingredient is what the company calls "ashwagandha exosomes". Its main results claim, visibly thicker hair in 90 days, is footnoted to "Nutrafol, Data on File, 2023": company data that we could not find published anywhere. The closest peer-reviewed work on the ingredient is a 2026 laboratory study on hair follicles kept alive outside the body, written partly by people with a commercial interest in it. That is interesting science and thin evidence, and it leaves the serum where its own label puts it: a cosmetic, not a treatment.
This entry is information only. It is drawn from Nutrafol's product page, PubMed and FDA pages as they stood on 18 October 2026. No clinician has checked it. Nobody here has used the product. Sudden, patchy, itchy or sore hair loss calls for a doctor before any serum.
The short verdict
The direct answer: a leave-on scalp product free of synthetic fragrance, with marketing that outruns its published evidence.
- What it is: a 1 oz leave-on serum, described as vegan and free of parabens, phthalates, silicones, sulfates, synthetic fragrance and drugs.
- What it claims: less shedding and breakage, and visibly thicker, fuller hair at around 90 days, all footnoted to unpublished company data.
- What we could find: no published trial of the serum on PubMed on 18 October 2026, and one 2026 laboratory study of the ashwagandha ingredient.
- What it costs: $49 for one bottle, which the company says lasts one to three months depending on how much of the scalp you treat.
- The evidence-led alternative: over-the-counter topical minoxidil, an FDA-approved drug with randomised trials, which pays this site nothing.
What's in the bottle
The direct answer: three named actives and a list of things it leaves out.
Nutrafol's page highlights ashwagandha exosomes, "filled with protein, RNA, and lipids", Irish moss peptides for volume, and pea sprout extract for "visibly thicker hair". It says the ashwagandha is upcycled from the plant used in its capsules and describes the exosomes as "1,500x smaller", without saying smaller than what. The full ingredient list sits behind a link on the page; the text version we read did not include it, so we do not reproduce it here.
The page also describes the serum as "100% drug-free" and "microbiome friendly", the latter certified by a private certification scheme, and says it is suitable for pregnant and breastfeeding individuals when used as intended, with a recommendation to consult a healthcare provider if in doubt. That is the company's statement. We found no independent safety data on the serum in pregnancy or breastfeeding, which is normal for cosmetics and is not the same as evidence of safety.
"Exosomes" on a label: what the word means here
The direct answer: tiny particles released by cells. In this serum they come from a plant, which makes them a different thing from the exosome products the FDA warns about.
Exosomes are microscopic membrane-bound sacs that cells release, carrying proteins, fats and genetic material between cells. Exosomes made from human or animal cells are being studied for hair loss, and some clinics already sell them as injections. The FDA's consumer page on regenerative medicine therapies, dated 3 June 2021, says such products, including stem cells and the products in its July 2020 alert on "stem cells and exosomes", need FDA approval to be marketed, are often marketed illegally, and carry risks it lists, including infections, unwanted immune reactions and tumour formation.
Those warnings concern biological products taken from human bodies and administered as treatments. They are not about a plant extract in a cosmetic serum, and it would be unfair to imply otherwise. The reverse is also true: the scientific excitement around human-derived exosomes does not transfer to a plant particle by sharing a name. Researchers usually call the plant versions "exosome-like nanovesicles" for exactly that reason.
The study Nutrafol cites, and what we could find
The direct answer: the product's results claims rest on unpublished company data; the ingredient has one laboratory paper.
Footnote 1 on the product page, attached to the 90-day and shedding claims, reads "Nutrafol, Data on File, 2023". Data on file is information a company holds but has not published, so readers cannot check its design, size, control group or measurements. The page also mentions a clinical study of 34 women aged 34 to 55 without saying which claim it supports or linking a paper, and cites a 2023 article by Townsend and colleagues. We read that article: it reports company tests of Nutrafol's scalp mask, shampoo, scalp essence and conditioner, and we found no hair serum data in it. A PubMed search for "nutrafol AND serum" returned no records.
The ingredient paper is Le Riche and colleagues in Experimental Dermatology, 2026. The team isolated exosome-like nanovesicles from ashwagandha and tested them on cultured human scalp cells and on individual human hair follicles dissected out and kept alive in the laboratory. Treated follicles stayed in their growth phase longer and produced more hair shaft, and growth factors such as VEGF-A rose. That is real laboratory work. It is also not a test on anyone's head, and the authors' conflict-of-interest statement lists employees of Unilever, a former employee of Nutrafol's parent company Nutraceutical Wellness, and says both companies have a commercial interest in ashwagandha.
| Claim on the product page | Source given | Can a reader check it? |
|---|---|---|
| Visibly thicker, healthier hair in 90 days | Nutrafol, Data on File, 2023 | No: unpublished |
| Clinical study of 34 women aged 34 to 55 | Footnote only; no paper named | No |
| Microbiome friendly | A private certification scheme | Partly: the certifier is named |
| Ashwagandha nanovesicles extend growth phase | Le Riche et al., Experimental Dermatology, 2026 | Yes, but laboratory follicles only |
Cosmetic vs drug: what a serum is allowed to claim
The direct answer: if it claimed to regrow hair, US law would treat it as a drug.
Under FDA guidance dated 11 September 2024, what a product is meant to do settles whether the law treats it as cosmetic or drug, and a promise to "restore hair growth" is named as one of the claims that makes something a drug. A separate federal rule, 21 CFR 310.527, says over-the-counter products sold as hair growers or to prevent hair loss need their own approved application, and calls labelling claims for such products without one false, misleading or unsupported.
That explains the vocabulary on the page: "visibly thicker", "visibly less shedding", "areas that felt thin look more covered". Those are claims about appearance, which a cosmetic may make. They are not claims that new hair grows, and nothing published that we could find shows that it does.
Price per month, dated
The direct answer: about $49 a month if you treat the whole scalp, less if you treat patches.
On 18 October 2026 the product page listed the serum at $49 for one 1 oz bottle, delivered once. Nutrafol's FAQ says a bottle typically lasts one to three months, closer to one month across the whole scalp and about three months on specific areas. At one bottle a month, a year comes to $588. Prices change, so treat that as a dated reading, not a quote.
| Product | What it is | Evidence | Listed price |
|---|---|---|---|
| Nutrafol Hair Serum | Cosmetic, drug-free, leave-on | Unpublished company data; one laboratory study of the key ingredient | $49 per 1 oz bottle |
| Vegamour GRO Hair Serum | Cosmetic, drug-free, leave-on | No published trial found on PubMed | $49 a month by subscription; $64 bought once |
| Topical minoxidil 2% or 5% | Approved by the FDA for sale without a prescription | Placebo-controlled trials, among them a 48-week study of 381 women | Varies; generics are sold by hundreds of labelers |
When we searched DailyMed, the National Library of Medicine's label database, on 18 October 2026, it held 574 labels for minoxidil products, most of them topical solutions and foams. Minoxidil has side effects and cautions of its own, including scalp irritation and unwanted facial hair, and its women's version carries a pregnancy and breastfeeding warning; a pharmacist can talk you through the label.
Who might reasonably try it
The direct answer: someone who wants a cosmetic scalp product, has had their hair loss diagnosed, and is comfortable paying for appearance rather than evidence.
The serum may suit someone who already uses a medical treatment and wants a pleasant leave-on product for appearance, or who cannot use minoxidil and accepts that this is not a substitute. It is a poor first choice while the cause of your hair loss is still unknown, because iron deficiency, thyroid disease and scarring conditions need a doctor, not a cosmetic. Our entry on getting iron, ferritin and vitamin D tested first explains that order.
If you decide to buy it, our Nutrafol link is an affiliate link; a first order through it can pay us a commission. Our Vegamour link, for comparison, works the same way. Neither changes the verdict above. For the capsules rather than the serum, see our full Nutrafol review.
Edge cases
You already use minoxidil. Nutrafol does not say how its serum interacts with minoxidil, and layering leave-on products can increase irritation. Ask the pharmacist or prescriber who advised the minoxidil.
You are pregnant or breastfeeding. The company says the serum is suitable when used as intended. That is a statement about its ingredients, not a study; ask your midwife or doctor.
You want it for eyebrows or lashes. Nutrafol's own FAQ says no: it was not tested for safety or efficacy there and should not be used near the eyes.
You have a sensitive or reactive scalp. Patch-test on a small area first, and stop if redness or itching appears.